PHF16 Inhibitors
PHF16 inhibitors encompass a diverse group of chemical compounds that operate through various mechanisms to alter the activity of PHF16. Some inhibitors function by directly affecting the enzymes responsible for modifying chromatin, such as histone deacetylases and methyltransferases. By changing the acetylation and methylation status of histones, these compounds can significantly influence the chromatin structure and, thus, the accessibility of DNA for transcriptional machinery. This can lead to an indirect impact on PHF16 by altering its substrate availability or by modulating the chromatin environment in which PHF16 operates. Other inhibitors in this category may target histone acetyltransferase enzymes, consequently affecting the balance of acetylation within the nucleus and indirectly influencing the activity of PHF16.
Additional inhibitors operate by disrupting protein degradation pathways. Proteasome inhibitors, for example, prevent the breakdown of ubiquitinated proteins, potentially causing an accumulation that may influence PHF16 activity due to altered protein turnover and interaction networks. Similarly, compounds that affect the autophagic degradation of proteins can alter cellular protein levels, including those of PHF16, by changing the dynamics of protein clearance. Certain inhibitors also interact with DNA directly, binding to it and inhibiting RNA synthesis, which could lead to a decrease in PHF16 expression through interference with its transcription.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that leads to an increase in acetylated histones, thereby altering chromatin structure and affecting PHF16 activity by changing its substrate availability. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that reduces DNA methylation, altering gene expression patterns and potentially decreasing PHF16 expression due to epigenetic changes. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that prevents the degradation of ubiquitinated proteins, potentially leading to a decrease in PHF16 activity due to altered protein turnover. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Raises lysosomal pH and affects autophagic degradation of proteins, which may impact PHF16 levels through disrupted protein clearance. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
Histone methyltransferase inhibitor that specifically targets G9a and GLP, which could indirectly affect PHF16 function by altering histone methylation patterns. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to DNA and inhibits RNA synthesis, potentially downregulating PHF16 expression by interfering with its transcription. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
Selective p300/CBP histone acetyltransferase inhibitor that affects acetylation levels of histones, possibly modifying PHF16 function due to changes in chromatin dynamics. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Histone deacetylase inhibitor that changes acetylation status of histones, potentially affecting PHF16 by modifying the chromatin environment where it operates. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
Inhibitor of G9a and GLP histone methyltransferases, potentially impacting PHF16 activity by altering histone methylation and chromatin structure. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor that affects histone acetylation levels and could thus indirectly impact PHF16 activity by modifying chromatin accessibility. | ||||||